LogicBio Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
– First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021
– First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021